Secondary adherence to non-vitamin-K antagonist oral anticoagulants in patients with atrial fibrillation in Sweden and the Netherlands

Adherence to Rivaroxaban, Dabigatran, and Apixaban for Stroke Prevention for Newly Diagnosed and Treatment-Naive Atrial Fibrillation Patients: An Update Using 2013-2014 Data

(2017) Joshua D. Brown et al.   Journal of Managed Care & Specialty Pharmacy

Comparison of Adherence to Rivaroxaban Versus Apixaban Among Patients With Atrial Fibrillation

(2016) Colleen A. McHorney et al.   CLINICAL THERAPEUTICS

Therapeutic compliance with rivaroxaban in preventing stroke in patients with non-valvular atrial fibrillation: CUMRIVAFA study

(2016) Emilio Márquez-Contreras et al.   CURRENT MEDICAL RESEARCH AND OPINION

Real-world persistence and adherence to oral anticoagulation for stroke risk reduction in patients with atrial fibrillation

(2016) Jan Beyer-Westendorf et al.   EUROPACE

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

(2016) Paulus Kirchhof et al.   EUROPEAN HEART JOURNAL

Factors associated with abrupt discontinuation of dabigatran therapy in patients with atrial fibrillation in Malaysia

(2016) Semira Abdi Beshir et al.   International Journal of Clinical Pharmacy

Adherence to non-vitamin-K-antagonist oral anticoagulant medications based on the Pharmacy Quality Alliance measure

(2015) Colleen A. McHorney et al.   CURRENT MEDICAL RESEARCH AND OPINION

Non-vitamin K antagonist oral anticoagulants: considerations on once- vs. twice-daily regimens and their potential impact on medication adherence

(2015) B. Vrijens et al.   EUROPACE

Site-Level Variation in and Practices Associated With Dabigatran Adherence

(2015) Supriya Shore et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Dabigatran adherence in atrial fibrillation patients during the first year after diagnosis: a nationwide cohort study

(2015) A. Gorst-Rasmussen et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Adherence to a Novel Oral Anticoagulant Among Patients with Atrial Fibrillation

(2015) Meijia Zhou et al.   Journal of Managed Care & Specialty Pharmacy

Medication persistence and discontinuation of rivaroxaban versus warfarin among patients with non-valvular atrial fibrillation

(2014) Winnie W. Nelson et al.   CURRENT MEDICAL RESEARCH AND OPINION

Medication Non-Adherence Among Elderly Patients Newly Discharged and Receiving Polypharmacy

(2014) L. Pasina et al.   DRUGS & AGING

Twice- or Once-Daily Dosing of Novel Oral Anticoagulants for Stroke Prevention: A Fixed-Effects Meta-Analysis with Predefined Heterogeneity Quality Criteria

(2014) Andreas Clemens et al.   PLoS One

Atrial fibrillation prevalence revisited

(2013) L. Friberg et al.   JOURNAL OF INTERNAL MEDICINE

Adherence to anticoagulant treatment with dabigatran in a real-world setting

(2013) S. Schulman et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Standardizing Terminology and Definitions of Medication Adherence and Persistence in Research Employing Electronic Databases

(2013) Marsha A. Raebel et al.   MEDICAL CARE

Edoxaban versus Warfarin in Patients with Atrial Fibrillation

(2013) Robert P. Giugliano et al.   NEW ENGLAND JOURNAL OF MEDICINE

The new oral anticoagulants in atrial fibrillation: Once daily or twice daily?

(2013) Giulia Renda et al.   VASCULAR PHARMACOLOGY

The population-based prescription database IADB.nl: its development, usefulness in outcomes research and challenges

(2013) Sipke T Visser et al.   Expert Review of Pharmacoeconomics & Outcomes Research

Characteristics of patients preferring once-daily controller therapy for asthma and COPD: a retrospective cohort study

(2013) David Price et al.   Primary Care Respiratory Journal

Impact of Daily Dosing Frequency on Adherence to Chronic Medications Among Nonvalvular Atrial Fibrillation Patients

(2012) François Laliberté et al.   ADVANCES IN THERAPY

2012 focused update of the ESC Guidelines for the management of atrial fibrillation

(2012) et al.   EUROPEAN HEART JOURNAL

Prescription drugs: Health in Sweden: The National Public Health Report 2012. Chapter 18

(2012) G. R. Weitoft et al.   SCANDINAVIAN JOURNAL OF PUBLIC HEALTH

Non-adherence to drug therapy and drug acquisition costs in a national population - a patient-based register study

(2011) Bo Hovstadius et al.   BMC HEALTH SERVICES RESEARCH

Apixaban versus Warfarin in Patients with Atrial Fibrillation

(2011) Christopher B. Granger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

(2011) Manesh R. Patel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach

(2009) Gregory Y.H. Lip et al.   CHEST

Good and poor adherence: optimal cut-point for adherence measures using administrative claims data

(2009) Sudeep Karve et al.   CURRENT MEDICAL RESEARCH AND OPINION

New Prescription Medication Gaps: A Comprehensive Measure of Adherence to New Prescriptions

(2009) Andrew J. Karter et al.   HEALTH SERVICES RESEARCH

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

(2009) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE